Revitalizing an early clinical program after a lead-compound setback

Challenge

A mid-size biotech faced a setback with its lead compound and needed a way to keep its early clinical program moving.

Approach

NGT mined the available PK data and designed a microdosing strategy to identify a viable path forward.

Outcome

The PK data mining and microdosing strategy revitalized the early clinical program.

Disciplines involved

Bring NGT into your program

Tell us where your program stands and which disciplines you need. A member of the team will follow up.